Related references
Note: Only part of the references are listed.Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up
F. Blok et al.
GYNECOLOGIC ONCOLOGY (2019)
Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
P. I. Stanciu et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Hereditary ovarian cancers: state of the art
Angela Toss et al.
MINERVA MEDICA (2019)
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers
Yael Laitman et al.
CANCER (2019)
Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study
L. Minig et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy
A. Stuursma et al.
MATURITAS (2018)
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study
Kala Visvanathan et al.
CANCER PREVENTION RESEARCH (2018)
BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls
Ang Li et al.
GYNECOLOGIC ONCOLOGY (2018)
Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations
A. Doren et al.
CLIMACTERIC (2018)
Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
Young-Jae Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study
Laura Cortesi et al.
ONCOLOGY (2017)
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know
F. De Felice et al.
CANCER TREATMENT REVIEWS (2017)
Racial Disparities in BRCA Testing and Cancer Risk Management Across a Population-Based Sample of Young Breast Cancer Survivors
Deborah Cragun et al.
CANCER (2017)
Hereditary Ovarian Cancer and Risk Reduction
Lesley Andrews et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)
Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy
Carolin Poon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Clinical and Pathological Characteristics of Incidental Diagnostic Early Occult Malignancy After Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers
Ofer Lavie et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations
Catherine A. Shu et al.
JAMA ONCOLOGY (2016)
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes
Angela Toss et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Risk management options elected by women after testing positive for a BRCA mutation
Christine Garcia et al.
GYNECOLOGIC ONCOLOGY (2014)
Pathologic Findings at Risk-Reducing Salpingo-Oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199
Mark E. Sherman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens
Welmoed Reitsma et al.
EUROPEAN JOURNAL OF CANCER (2013)
Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers
Janice S. Kwon et al.
OBSTETRICS AND GYNECOLOGY (2013)
Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status
R. Manchanda et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)
Microscopic and Early-Stage Ovarian Cancers in BRCA1/2 Mutation Carriers: Building a Model for Early BRCA-Associated Tumorigenesis
Melinda S. Yates et al.
CANCER PREVENTION RESEARCH (2011)
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation
A. Finch et al.
GYNECOLOGIC ONCOLOGY (2011)
Ovarian Pathology in Risk-reducing Salpingo-oophorectomies From Women With BRCA Mutations, Emphasizing the Differential Diagnosis of Occult Primary and Metastatic Carcinoma
Joseph T. Rabban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
Nienke M. van der Velde et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Primary Fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
Michael J. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study
Walter A. Rocca et al.
LANCET ONCOLOGY (2006)
Prophylactic bilateral salpingo-oophorectomy comnared with surveillance in women with BRCA mutations
Kathleen M. Schmeler et al.
OBSTETRICS AND GYNECOLOGY (2006)
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
A Finch et al.
GYNECOLOGIC ONCOLOGY (2006)
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer
JB Madalinska et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy
CB Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations:: A decision analysis
K Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
We of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
K Yoshida et al.
CANCER SCIENCE (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Share Paper
